Huo X, Zhang K, Yi L, Mo Y, Liang Y, Zhao J, Zhang Z, Xu Y, Zhen G
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Key Laboratory of Respiratory Diseases, National Health and Family Planning Commission of the People's Republic of China, Wuhan, China.
Clin Exp Allergy. 2016 Oct;46(10):1281-90. doi: 10.1111/cea.12754. Epub 2016 Jun 6.
Airway eosinophilic inflammation is a pivotal feature of asthma. Epithelial cells play critical roles in airway eosinophilia. We hypothesized that epithelial microRNAs (miRNAs) are involved in airway eosinophilia.
This study investigated the associations between epithelial and plasma miR-181b-5p and airway eosinophilic inflammation, and the possible mechanism by which miR-181b-5p participates in eosinophilic inflammation.
Epithelial miRNAs expression was profiled by miRNA array in eight subjects with asthma and four healthy controls. Epithelial miR-181b-5p expression was confirmed by quantitative PCR in the subjects for array experiment and another cohort including 21 subjects with asthma and 10 controls. Plasma miR-181b-5p was determined by quantitative PCR in 72 subjects with asthma and 35 controls. Correlation assays between epithelial and plasma miR-181b-5p expression and airway eosinophilia were performed. The target of miR-181b-5p, SPP1, was predicted by online algorithms and verified in BEAS-2B cells. The role of miR-181b-5p in epithelial proinflammatory cytokine expression was examined in an in vitro system.
Epithelial miR-181b-5p expression was decreased in subjects with asthma. Epithelial miR-181b-5p levels were inversely correlated with sputum and bronchial submucosal eosinophilia. Plasma miR-181b-5p was decreased and correlated with epithelial miR-181b-5p in subjects with asthma. There was a strong inverse correlation between plasma miR-181b-5p and airway eosinophilia in subjects with asthma. Plasma miR-181b-5p was increased after inhaled corticosteroids treatment. We verified that SPP1 is a target of miR-181b-5p. In human bronchial epithelial cells, miR-181b-5p regulated IL-13-induced IL-1β and CCL11 expression by targeting SPP1. Dexamethasone restored IL-13-induced miR-181b-5p down-regulation and suppressed IL-13-induced SPP1, IL-1β and CCL11 expression.
Epithelial and plasma miR-181b-5p are potential biomarkers for airway eosinophilia in asthma. MiR-181b-5p may participate in eosinophilic airway inflammation by regulating proinflammatory cytokines expression via targeting SPP1.
气道嗜酸性粒细胞炎症是哮喘的关键特征。上皮细胞在气道嗜酸性粒细胞增多中起关键作用。我们推测上皮微小RNA(miRNA)参与气道嗜酸性粒细胞增多。
本研究调查上皮和血浆miR-181b-5p与气道嗜酸性粒细胞炎症之间的关联,以及miR-181b-5p参与嗜酸性粒细胞炎症的可能机制。
通过miRNA芯片分析8例哮喘患者和4例健康对照的上皮miRNA表达。通过定量PCR在进行芯片实验的受试者以及另一个包括21例哮喘患者和10例对照的队列中确认上皮miR-181b-5p表达。通过定量PCR测定72例哮喘患者和35例对照的血浆miR-181b-5p。进行上皮和血浆miR-181b-5p表达与气道嗜酸性粒细胞增多之间的相关性分析。通过在线算法预测miR-181b-5p的靶标SPP1,并在BEAS-2B细胞中进行验证。在体外系统中研究miR-181b-5p在上皮促炎细胞因子表达中的作用。
哮喘患者上皮miR-181b-5p表达降低。上皮miR-181b-5p水平与痰液和支气管黏膜下嗜酸性粒细胞增多呈负相关。哮喘患者血浆miR-181b-5p降低且与上皮miR-181b-5p相关。哮喘患者血浆miR-181b-5p与气道嗜酸性粒细胞增多之间存在强烈的负相关。吸入糖皮质激素治疗后血浆miR-181b-5p升高。我们验证了SPP1是miR-181b-5p的靶标。在人支气管上皮细胞中,miR-181b-5p通过靶向SPP1调节IL-13诱导的IL-1β和CCL11表达。地塞米松恢复IL-13诱导的miR-181b-5p下调并抑制IL-13诱导的SPP1、IL-1β和CCL11表达。
上皮和血浆miR-181b-5p是哮喘气道嗜酸性粒细胞增多的潜在生物标志物。MiR-181b-5p可能通过靶向SPP1调节促炎细胞因子表达来参与嗜酸性气道炎症。